- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Hyperuricemia and gout closely associated with development of diabetes
A new study published in Current Diabetes Reports suggests that when compared to people who are healthy, people with hyperuricemia and gout are more likely to develop diabetes.
Chronic hyperglycemia is the primary symptom of diabetes mellitus (DM), a disorder of metabolism that affects a variety of metabolic processes. The byproduct of purine catabolism is uric acid (UA). A rise in serum UA, also known as hyperuricemia, can result from either an
increase in UA production or a reduction in UA excretion, or from a combination of both. When Uric acid levels in the blood rise, gout typically results. The body produces this acid as waste when it breaks down purines, which are nutrients found in some foods and body tissue. To determine the prevalence of diabetes in individuals with hyperuricemia and gout, Jinguo Jiang and colleagues conducted a comprehensive review and meta-analysis.
The recent findings highlighted in this study were as follows:
1. The higher risk of diabetes is linked to hyperuricemia and gout, according to earlier research.
2. According to a recent meta-analysis, 16% of gout patients also had diabetes. In the meta-
analysis, 38 studies (458,256 patients) were taken into account.
3. Patients with hyperuricemia and gout had combined diabetes prevalence rates of 19.10% and 16.70%, respectively.
4. Compared to patients from other continents, North American patients had a great prevalence of diabetes.
5. Diabetes was more prevalent in older individuals with hyperuricemia and those taking
diuretics than in younger patients and those not taking diuretics.
6. The prevalence of diabetes was greater in studies with a short sample size, a case-control
design, and a poor quality score than in studies with a big sample size, alternative designs, and a high quality score.
7. Among patients with hyperuricemia and gout, diabetes is very common.
8. For the prevention of diabetes, individuals with hyperuricemia and gout must have their plasma glucose and uric acid levels under control.
In conclusion, as a result of this study, it is essential to keep plasma glucose and uric acid levels under control in these individuals in order to prevent the development of diabetes.
Reference:
Jiang, J., Zhang, T., Liu, Y., Chang, Q., Zhao, Y., Guo, C., & Xia, Y. (2023). Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis. In Current Diabetes Reports. Springer Science and Business Media LLC. https://doi.org/10.1007/s11892-023-01506-2
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751